FOCLIVIA sol inj flac 75 µg 5 ml 10 pce

7680661610010 CH-66161 J07BB02 08.08.
FOCLIVIA sol inj flac 75 µg 5 ml 10 pce
FOCLIVIA sol inj flac 75 µg 5 ml 10 pce
FOCLIVIA sol inj flac 75 µg 5 ml 10 pce
1 / 3
google

Details

Product number
6616101
CPT
-
Packaging group
10
Unit
Durchstechflasche(n)
Composition
haemagglutininum influenzae A (H5N1) 7.5 µg et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14), adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, thiomersalum 50 µg, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml, natrium 1.9 mg, kalium 0.08 mg.

Articles (1)

Foclivia, Injektionssuspension in einer Durchstechflasche
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H5N1)
7.5 UG Substance Wirkstoff (Principe actif)
neuraminidasum inactivatum
- Substance Wirkstoff (Principe actif)
squalenum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
sorbitani trioleas
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
thiomersalum
50.0 UG Substance HBESI
aqua ad iniectabile
- Substance HNIDK
natrium
1.9 MG Substance HBESI
kalium
0.08 MG Substance HBESI

Authorization holder

Vifor (International) Inc.

9014 St. Gallen

Authorization information

Swissmedic authorization number
66161
Drug name
Foclivia, Injektionssuspension in einer Durchstechflasche
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
20/04/2018
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
Pandemischer Influenza Impfstoff

Packaging details

Description (FR)
FOCLIVIA sol inj flac 75 µg 5 ml 10 pce
Description (DE)
FOCLIVIA Inj Lös Dfl 75 µg 5 ml 10 Stk
Market launch
20/04/2018
Narcotic (BTM)
No
Buy us a coffee Explore the data